First International TNBC Conference meeting report Journal Article
| Authors: | Rida, P.; Ogden, A.; Ellis, I. O.; Varga, Z.; Wolff, A. C.; Traina, T. A.; Hatzis, C.; Palmer, J. R.; Ambrosone, C. B.; Lehmann, B. D.; Nanda, R.; Rice, V. M.; Brawley, O. W.; Torres, M. A.; Rakha, E.; Aneja, R. |
| Article Title: | First International TNBC Conference meeting report |
| Abstract: | Recently, Georgia State University’s Centennial Hall was the premier location for the 2017 International Conference on Triple Negative Breast Cancer (TNBC): Illuminating Actionable Biology, which was held from Sept. 18 to 20, 2017, in Atlanta, USA. The conference featured a stellar line-up of domestic and international speakers and diverse participants including TNBC survivors, luminaries in breast cancer research, medical students and fellows, clinicians, translational researchers, epidemiologists, biostatisticians, bioinformaticians, and representatives from the industry. This report distills the burning questions that spiked the event and summarizes key themes, findings, unique opportunities and future directions that emerged from this confluence of thought leaders. © 2018, Springer Science+Business Media, LLC, part of Springer Nature. |
| Keywords: | review; cancer risk; drug targeting; cancer research; cancer therapy; risk factor; immunotherapy; molecular biology; race difference; health care delivery; personalized medicine; racial disparities; molecularly targeted therapy; triple negative breast cancer; molecular subtypes; human; priority journal; breast cancer molecular subtype; targeted drugs; health equity |
| Journal Title: | Breast Cancer Research and Treatment |
| Volume: | 169 |
| Issue: | 3 |
| ISSN: | 0167-6806 |
| Publisher: | Springer |
| Date Published: | 2018-06-01 |
| Start Page: | 407 |
| End Page: | 412 |
| Language: | English |
| DOI: | 10.1007/s10549-018-4692-3 |
| PROVIDER: | scopus |
| PMCID: | PMC5955852 |
| PUBMED: | 29417299 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 2 July 2018 -- Source: Scopus |
